A preclinical study led by the Smidt Heart Institute at Cedars-Sinai challenges the assumption that blocking the NCX1 protein, which regulates calcium levels in cells, is more effective than maintaining its activity during a heart attack to limit damage.
This article was originally published on MedicalXpress.com